Adoptive transfer of tumor infiltrating lymphocytes (TIL)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adoptive transfer of tumor infiltrating lymphocytes (TIL), covering 2025-07-10 to 2025-07-10. Get the full timeline:
Most recent: Clinical Trial Update: Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers [Phase 2]